机译:用鞘内蓖麻毒素,高剂量甲氨蝶呤和R-DHAP治疗次级中枢神经系统淋巴瘤,然后进行自体干细胞移植:HOVON 80阶段2研究的结果
Department of HematologyErasmus MC Cancer InstituteRotterdam The Netherlands;
Department of HematologyUniversity Medical Center GroningenGroningen The Netherlands;
HOVON Data CenterErasmus MC Cancer Institute‐Clinical Trial CenterRotterdam The Netherlands;
Department of Internal MedicineMaastricht University Medical CenterMaastricht The Netherlands;
Department of Internal MedicineMedisch Spectrum TwenteEnschede The Netherlands;
Department of HematologyRadboud University Medical CenterNijmegen The Netherlands;
Department of Medical OncologyAntoni van Leeuwenhoek HospitalAmsterdam The Netherlands;
Department of HematologyAcademic Medical CenterAmsterdam The Netherlands;
Department of HematologyErasmus MC Cancer InstituteRotterdam The Netherlands;
Department of Neuro‐oncologyErasmus MC Cancer InstituteRotterdam The Netherlands;
Department of NeurologyUniversity Medical Center GroningenGroningen The Netherlands;
HOVON Data CenterErasmus MC Cancer Institute‐Clinical Trial CenterRotterdam The Netherlands;
Department of Radiation OncologyRadboud University Medical CenterNijmegen The Netherlands;
Department of Neuro‐oncologyErasmus MC Cancer InstituteRotterdam The Netherlands;
clinical trial; methotrexate; rituximab; secondary CNS lymphoma; transplantation; treatment;
机译:用鞘内蓖麻毒素,高剂量甲氨蝶呤和R-DHAP治疗次级中枢神经系统淋巴瘤,然后进行自体干细胞移植:HOVON 80阶段2研究的结果
机译:非霍奇金淋巴瘤合并中枢神经系统患者大剂量利妥昔单抗联合大剂量阿糖胞苷动员疗法和大剂量噻托帕,白消安和环磷酰胺自体干细胞移植的2期试验
机译:相2试验高剂量蓖麻毒素动员治疗和高剂量Thiotepa,Busulfan和环磷酰胺自体干细胞移植患者,中枢神经系统受到非霍奇金淋巴瘤的患者
机译:用高剂量甲氨蝶呤(HD-MTX)的中枢神经系统(CNS)复发性移植后移植淋巴结疾病(PTLD)的处理
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:前瞻性大剂量化学疗法的反应适应性治疗然后自体干细胞移植抢救或巩固期大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤:一项长期的单中心研究
机译:前瞻性大剂量化学疗法的反应适应性治疗,然后自体干细胞移植抢救或巩固期大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤:一项长期的单中心研究